About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Phoenix | 111 Studies

Clinical Trials MigrainePhoenix

Migraine Clinical Trials in Phoenix

Find 111 clinical trials for migraine near Phoenix, Arizona. Connect with research centers in your area.

All Migraine trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 111 trials

CompletedA Study of the Efficacy of RWJ-333369 in the Prevention of MigraineThe purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual…NCT00109083·Northport, Alabama and 24 others CompletedPREMIUM Migraine TrialThe Purpose of this study is to evaluate the impact of percutaneous closure of a patent foramen ovale (PFO) (a hole in the heart), using the AMPLATZER PFO Occluder, on the…NCT00355056·Phoenix, Arizona and 29 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedComparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineThe study is being conducted to evaluate two doses of TEV-48125 in adult patients with chronic migraineNCT02621931·Birmingham, Alabama and 272 others

CompletedEfficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of MigraineThis study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.NCT02867709·Birmingham, Alabama and 108 others

CompletedAssessment of Safety and Efficacy of Nerivio for the Migraine PreventionMigraine is a common neurologic with attacks of headache and associated symptoms such as nausea, vomiting, phono and photophobia.NCT04828707·Phoenix, Arizona and 15 others

CompletedAssessment of LBR-101 In Chronic MigraineThe purpose of the study is to determine whether monthly subcutaneous administration of LBR-101 (fremanezumab) is safe and provides migraine prevention in patients with chronic…NCT02021773·Gilbert, Arizona and 56 others

CompletedA Study of LY2951742 in Participants With MigraineTo assess the efficacy and safety of LY2951742 in the prevention of migraine headache in migraineurs with or without aura during 3 months of treatment.NCT01625988·Gilbert, Arizona and 36 others

CompletedThe MOTS (Medication Overuse Treatment Strategy) TrialThere are two commonly used treatment strategies for treating patients who have chronic migraine with medication overuse.NCT02764320·Flagstaff, Arizona and 28 others

CompletedEfficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineThe study is being conducted to evaluate two doses of TEV-48125 in adult patients with episodic migraineNCT02629861·Birmingham, Alabama and 274 others

Active not recruitingA Study to Evaluate White Matter Hyperintensities in MigraineThe purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migrainesNCT05112289·Phoenix, Arizona

CompletedA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of MigraineStudy STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101…NCT03901482·Birmingham, Alabama and 116 others

CompletedEvaluation of ALD403 (Eptinezumab) in the Prevention of Chronic MigraineThe purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.NCT02974153·Birmingham, Alabama and 143 others

CompletedMaximizing Outcomes in Treating Acute MigraineAXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in…NCT03896009·Birmingham, Alabama and 84 others

CompletedMigraine Study in Adolescent PatientsThis study was designed to determine how well the combination medication, sumatriptan and naproxen sodium, treats migraine headache in adolescents 12-17 years oldNCT00843024·Gilbert, Arizona and 78 others

CompletedA Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of MigraineThis is an open-label, twelve-month safety study. There is a screening period followed by a run-in period to record migraine activity.NCT03282227·Birmingham, Alabama and 30 others

CompletedA Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine HeadacheThe purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.NCT00055484·Huntsville, Alabama and 12 others

CompletedAcute Treatment Trial in Adult Subjects With MigrainesThe purpose of the study is to evaluate the safety and efficacy of three different intranasal dose levels of zavegepant (BHV-3500), relative to placebo, in the acute treatment of…NCT03872453·Mobile, Alabama and 81 others

Active not recruitingA Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigraineThe purpose of this study is to learn about the effect of a study medicine called rimegepant in adolescents who have frequent migraine attacks.NCT06616194·Phoenix, Arizona and 101 others

CompletedA Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of MigraineStudy STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101…NCT04940390·Chandler, Arizona and 126 others

CompletedBiomarker Study in Participants With MigraineThis is a study of participants with a diagnosis of migraine who completed another clinical trial NCT02163993. The participants received either LY2951742 or placebo.NCT02766517·Phoenix, Arizona and 13 others

Page 1 of 6Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia